COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR AGAINST LOPINAVIR/RITONAVIR IN THE TREATMENT OF PEOPLE LIVING WITH HIV IN PERU
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1228
https://www.valueinhealthjournal.com/article/S1098-3015(16)01296-1/fulltext
Title :
COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR AGAINST LOPINAVIR/RITONAVIR IN THE TREATMENT OF PEOPLE LIVING WITH HIV IN PERU
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01296-1&doi=10.1016/j.jval.2016.03.1228
First page :
A218
Section Title :
Infection - Cost Studies
Open access? :
No
Section Order :
728